See more : Vantage Knowledge Academy Limited (VKAL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Research Solutions, Inc. (RSSS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Research Solutions, Inc., a leading company in the Software – Application industry within the Technology sector.
- Thitikorn Public Company Limited (TK.BK) Income Statement Analysis – Financial Results
- Oxford Lane Capital Corp. (OXLCN) Income Statement Analysis – Financial Results
- AMTD IDEA Group (HKB.SI) Income Statement Analysis – Financial Results
- Hunter Douglas NV (HUNDP.AS) Income Statement Analysis – Financial Results
- City Developments Limited (CDEVF) Income Statement Analysis – Financial Results
Research Solutions, Inc. (RSSS)
About Research Solutions, Inc.
Research Solutions, Inc., through its subsidiaries, provides cloud-based software-as-a-service research platform. The company is also involved in the transactional sale of published scientific, technical, and medical (STM) content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to accelerate their research and development activities with access and management STM articles used throughout the intellectual property development lifecycle. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was founded in 2006 and is based in Henderson, Nevada.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 44.62M | 37.70M | 32.93M | 31.76M | 31.06M | 28.79M | 28.02M | 25.75M | 34.36M | 31.90M | 36.55M | 45.50M | 42.82M | 33.50M | 24.94M | 14.65M | 12.21M | 3.85M |
Cost of Revenue | 24.98M | 23.00M | 20.91M | 21.47M | 21.42M | 20.45M | 20.67M | 19.64M | 27.86M | 25.72M | 28.20M | 35.95M | 34.78M | 29.59M | 21.02M | 11.41M | 10.02M | 3.25M |
Gross Profit | 19.64M | 14.70M | 12.02M | 10.29M | 9.64M | 8.34M | 7.35M | 6.10M | 6.50M | 6.18M | 8.35M | 9.55M | 8.04M | 3.91M | 3.92M | 3.24M | 2.19M | 597.63K |
Gross Profit Ratio | 44.01% | 38.99% | 36.50% | 32.39% | 31.03% | 28.98% | 26.23% | 23.71% | 18.92% | 19.36% | 22.83% | 20.99% | 18.78% | 11.66% | 15.71% | 22.11% | 17.90% | 15.52% |
Research & Development | 5.44M | 3.74M | 3.71M | 2.64M | 2.12M | 2.14M | 1.80M | 1.48M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 10.67M | 8.50M | 7.50M | 5.88M | 5.82M | 5.32M | 5.18M | 5.65M | 6.83M | 6.40M | 9.62M | 9.07M | 0.00 | 7.87M | 3.59M | 4.02M | 2.17M | 981.12K |
Selling & Marketing | 3.44M | 2.29M | 2.28M | 2.07M | 2.51M | 2.08M | 2.18M | 3.39M | 5.29K | 0.00 | 0.00 | 0.00 | 0.00 | 618.98K | 439.88K | 158.52K | 40.44K | 23.66K |
SG&A | 14.11M | 14.41M | 9.78M | 7.95M | 8.32M | 7.40M | 7.36M | 9.03M | 6.83M | 6.40M | 9.62M | 9.07M | 10.72M | 8.49M | 4.03M | 4.18M | 2.21M | 1.00M |
Other Expenses | 857.67K | 338.62K | 17.65K | 11.52K | 23.65K | 38.82K | 58.18K | 23.86K | -31.61K | 1.22K | -15.56K | -84.02K | 3.97M | 673.88K | 206.62K | 235.66K | 341.47K | 0.00 |
Operating Expenses | 20.41M | 14.46M | 13.51M | 10.61M | 10.47M | 9.57M | 9.31M | 9.17M | 6.92M | 6.57M | 10.13M | 9.66M | 12.18M | 9.16M | 4.24M | 4.41M | 2.55M | 1.10M |
Cost & Expenses | 45.39M | 37.46M | 34.42M | 32.08M | 31.89M | 30.02M | 29.98M | 28.81M | 34.78M | 32.30M | 38.33M | 45.61M | 46.96M | 38.76M | 25.26M | 15.83M | 12.58M | 4.35M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.38K | 3.23K | 4.17K | 39.53K | 111.34K | 88.49K |
Interest Expense | 0.00 | 0.00 | 136.74K | 0.00 | 0.00 | 0.00 | 4.00K | 12.00K | 17.38K | 18.06K | 55.92K | 89.41K | 220.67K | 144.07K | 6.92K | 34.99K | 32.31K | 6.35K |
Depreciation & Amortization | 836.27K | 52.65K | 17.65K | 83.85K | 143.57K | 153.90K | 262.99K | 133.69K | 90.85K | 174.82K | 507.68K | 617.90K | 1.53M | 750.19K | 270.98K | 283.58K | 278.49K | 44.18K |
EBITDA | 66.73K | 291.26K | -1.47M | -235.14K | -628.28K | -1.08M | -1.63M | -2.93M | -1.23M | -318.42K | -834.28K | 897.56K | -5.10M | -4.51M | -40.61K | -684.37K | -17.02K | -443.63K |
EBITDA Ratio | 0.15% | 0.77% | -4.03% | -0.85% | -2.15% | -3.37% | -5.84% | -11.11% | -1.05% | -0.69% | -3.52% | 0.92% | -6.09% | -13.44% | -0.18% | -5.78% | -0.46% | -11.52% |
Operating Income | -769.54K | 238.61K | -1.49M | -318.99K | -832.37K | -1.23M | -1.95M | -3.08M | -420.70K | -494.45K | -1.78M | 363.69K | -6.65M | -5.26M | -321.18K | -1.17M | -367.81K | -502.62K |
Operating Income Ratio | -1.72% | 0.63% | -4.52% | -1.00% | -2.68% | -4.27% | -6.96% | -11.98% | -1.22% | -1.55% | -4.87% | 0.80% | -15.54% | -15.69% | -1.29% | -8.01% | -3.01% | -13.05% |
Total Other Income/Expenses | -2.90M | 338.62K | 7.15K | 1.15K | 80.04K | 107.31K | 54.18K | 11.86K | -48.99K | -16.84K | -13.05K | -173.43K | -202.02K | -150.72K | 2.67K | 136.81K | 29.49K | 82.14K |
Income Before Tax | -3.67M | 577.23K | -1.62M | -281.89K | -771.85K | -1.15M | -1.90M | -3.07M | -469.70K | -511.29K | -1.85M | 190.25K | -6.85M | -5.41M | -318.51K | -1.03M | -401.47K | 0.00 |
Income Before Tax Ratio | -8.23% | 1.53% | -4.93% | -0.89% | -2.49% | -3.99% | -6.77% | -11.93% | -1.37% | -1.60% | -5.06% | 0.42% | -16.01% | -16.14% | -1.28% | -7.06% | -3.29% | 0.00% |
Income Tax Expense | 113.07K | 5.60K | 7.62K | 3.20K | 7.84K | 27.04K | 39.78K | 35.50K | 28.16K | 30.89K | 16.10K | -1.67K | -322.11K | 144.07K | 1.13K | 32.17K | -29.49K | -72.32K |
Net Income | -3.79M | 571.62K | -1.63M | -285.09K | -779.69K | -1.17M | -1.68M | -2.29M | -497.86K | 774.22K | -1.87M | 191.92K | -6.53M | -5.41M | -307.19K | -1.07M | -338.32K | -415.49K |
Net Income Ratio | -8.49% | 1.52% | -4.96% | -0.90% | -2.51% | -4.08% | -5.99% | -8.91% | -1.45% | 2.43% | -5.11% | 0.42% | -15.26% | -16.14% | -1.23% | -7.28% | -2.77% | -10.79% |
EPS | -0.13 | 0.02 | -0.06 | -0.01 | -0.03 | -0.05 | -0.07 | -0.10 | -0.03 | 0.04 | -0.11 | 0.01 | -0.38 | -0.36 | -0.02 | -0.08 | -0.03 | -0.04 |
EPS Diluted | -0.13 | 0.02 | -0.06 | -0.01 | -0.03 | -0.05 | -0.07 | -0.10 | -0.03 | 0.04 | -0.11 | 0.01 | -0.38 | -0.36 | -0.02 | -0.08 | -0.03 | -0.04 |
Weighted Avg Shares Out | 28.86M | 26.86M | 26.42M | 26.01M | 24.76M | 23.82M | 23.47M | 23.24M | 17.05M | 17.45M | 17.23M | 17.12M | 17.05M | 14.96M | 12.97M | 12.95M | 12.54M | 10.63M |
Weighted Avg Shares Out (Dil) | 28.86M | 29.14M | 26.42M | 26.01M | 24.76M | 23.82M | 23.47M | 23.24M | 17.77M | 17.96M | 17.23M | 17.26M | 17.05M | 14.96M | 12.97M | 12.95M | 12.54M | 10.63M |
Research Solutions to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference on Wednesday, January 24
Research Solutions Announces Acquisition of scite
Research Solutions, Inc. (RSSS) Q1 2024 Earnings Call Transcript
Research Solutions to Participate in Pair of Investor Conferences
Research Solutions to Announce First Quarter Fiscal 2024 Results on Thursday, November 9, 2023
Research Solutions, Inc. (RSSS) Q4 2023 Earnings Call Transcript
Research Solutions Inc. (RSSS) Surpasses Q4 Earnings and Revenue Estimates
Research Solutions Announces Fiscal Fourth Quarter and Full Year 2023 Results
Research Solutions & Clinitech India Partner to Transform Medical Education
Source: https://incomestatements.info
Category: Stock Reports